Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Vincenza Conteduca

Showing results (91-100 of 157) with videos related to

Pageof 16
Sort By:
NPJ Precision Oncology|August 13, 2021
Circulating tumor cell heterogeneity in neuroendocrine prostate cancer by single cell copy number analysisVincenza Conteduca, Sheng-Yu Ku, Luisa Fernandez, et al.
British Journal of Cancer|August 1, 2021
Circulating androgen receptor gene amplification and resistance to <sup>177</sup>Lu-PSMA-617 in metastatic castration-resistant prostate cancer: results of a Phase 2 trialUgo De Giorgi, Maddalena Sansovini, Stefano Severi, et al.
BMC Cancer|December 21, 2018
Oxaliplatin plus leucovorin and 5-fluorouracil (FOLFOX-4) as a salvage chemotherapy in heavily-pretreated platinum-resistant ovarian cancerVincenza Conteduca, Giorgia Gurioli, Lorena Rossi, et al.
British Journal of Cancer|July 17, 2020
Plasma tumour DNA as an early indicator of treatment response in metastatic castration-resistant prostate cancerVincenza Conteduca, Daniel Wetterskog, Emanuela Scarpi, et al.
Cancers|November 7, 2019
Plasma Androgen Receptor in Prostate CancerVincenza Conteduca, Giorgia Gurioli, Nicole Brighi, et al.
Expert Review of Anticancer Therapy|June 30, 2026
Predictive biomarkers of response in metastatic prostate cancer: paving the way for a new era of precision medicineChiara Mercinelli, Fabrizio Di Costanzo, Christoph Oing, et al.
Molecular Cancer Therapeutics|March 5, 2020
SLFN11 Expression in Advanced Prostate Cancer and Response to Platinum-based ChemotherapyVincenza Conteduca, Sheng-Yu Ku, Loredana Puca, et al.
Urologic Oncology|February 7, 2018
Association among metabolic syndrome, inflammation, and survival in prostate cancerVincenza Conteduca, Orazio Caffo, Luca Galli, et al.
Cancers|January 21, 2023
Serum Mass Spectrometry Proteomics and Protein Set Identification in Response to FOLFOX-4 in Drug-Resistant Ovarian CarcinomaDomenico D'Arca, Leda Severi, Stefania Ferrari, et al.
Future Oncology (London, England)|March 20, 2019
Activity and safety of metronomic cyclophosphamide in the modern era of metastatic castration-resistant prostate cancerOrazio Caffo, Gaetano Facchini, Elisa Biasco, et al.
Pageof 16

Showing results (91-100 of 157) with videos related to

Sort By:
Pageof 16
NPJ Precision Oncology|August 13, 2021
Circulating tumor cell heterogeneity in neuroendocrine prostate cancer by single cell copy number analysisVincenza Conteduca, Sheng-Yu Ku, Luisa Fernandez, et al.
British Journal of Cancer|August 1, 2021
Circulating androgen receptor gene amplification and resistance to <sup>177</sup>Lu-PSMA-617 in metastatic castration-resistant prostate cancer: results of a Phase 2 trialUgo De Giorgi, Maddalena Sansovini, Stefano Severi, et al.
BMC Cancer|December 21, 2018
Oxaliplatin plus leucovorin and 5-fluorouracil (FOLFOX-4) as a salvage chemotherapy in heavily-pretreated platinum-resistant ovarian cancerVincenza Conteduca, Giorgia Gurioli, Lorena Rossi, et al.
British Journal of Cancer|July 17, 2020
Plasma tumour DNA as an early indicator of treatment response in metastatic castration-resistant prostate cancerVincenza Conteduca, Daniel Wetterskog, Emanuela Scarpi, et al.
Cancers|November 7, 2019
Plasma Androgen Receptor in Prostate CancerVincenza Conteduca, Giorgia Gurioli, Nicole Brighi, et al.
Expert Review of Anticancer Therapy|June 30, 2026
Predictive biomarkers of response in metastatic prostate cancer: paving the way for a new era of precision medicineChiara Mercinelli, Fabrizio Di Costanzo, Christoph Oing, et al.
Molecular Cancer Therapeutics|March 5, 2020
SLFN11 Expression in Advanced Prostate Cancer and Response to Platinum-based ChemotherapyVincenza Conteduca, Sheng-Yu Ku, Loredana Puca, et al.
Urologic Oncology|February 7, 2018
Association among metabolic syndrome, inflammation, and survival in prostate cancerVincenza Conteduca, Orazio Caffo, Luca Galli, et al.
Cancers|January 21, 2023
Serum Mass Spectrometry Proteomics and Protein Set Identification in Response to FOLFOX-4 in Drug-Resistant Ovarian CarcinomaDomenico D'Arca, Leda Severi, Stefania Ferrari, et al.
Future Oncology (London, England)|March 20, 2019
Activity and safety of metronomic cyclophosphamide in the modern era of metastatic castration-resistant prostate cancerOrazio Caffo, Gaetano Facchini, Elisa Biasco, et al.
Pageof 16